通过对抗原-Ia复合体的抗体对实验性过敏性脑膜炎的免疫调节
R Aharoni1, D Teitelbaum, R Arnon
1Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.
Nature
|May 9, 1991
概括
用抗体向特定的自身抗原和MHC分子复合体,为自身免疫性疾病 (如实验性过敏性脑膜炎) 提供了一种新的治疗方法. 这种方法可以选择性地阻止有害的T细胞反应,而不会影响有益的免疫功能.
科学领域:
- 免疫学 免疫学 免疫学
- 自免疫性疾病 自免疫性疾病
- 神经免疫学 神经免疫学
背景情况:
- 自身免疫性疾病涉及T淋巴细胞错误地识别由MHCII类分子呈现的自我抗原.
- 目前针对抗原-MHC-TCR复合物的单个成分的治疗方法可能会导致非目标免疫效应.
- 实验性过敏性脑膜炎 (EAE) 是由CD4+T细胞介导的自身免疫疾病的一个模型.
研究的目的:
- 开发和测试一种针对特定的自身抗原-MHC复合体的新型治疗策略.
- 在自身免疫性疾病模型中,研究专门与自身抗原-MHC复合体结合的抗体的疗效.
主要方法:
- 产生针对髓基蛋白 (BP) 复合体和自我IA的单克隆抗体.
- 在体外评估抗体对T细胞增殖的作用,以应对BP和对照抗原.
- 在H-2s小鼠实验性过敏脑炎 (EAE) 抑制抗体功效的体内测试.
主要成果:
- 单克隆抗体特别识别了BP和IA复合体.
- 这些抗体在体外阻断了T细胞对脑原性BP决定因子的增殖,并降低了对完整BP的反应.
- 抗体治疗在小鼠中显著抑制了EAE的发展,而不会影响对非相关抗原的反应.
结论:
- 针对独特的自身抗原-MHC复合体的抗体提供一种高度选择性的阻断病原性T细胞反应.
- 这一战略表明了对自身免疫性疾病的有效和特定治疗的潜力.
- 准三分子复合体为自身免疫性疾病治疗提供了一个有前途的途径.
更多相关视频
09:46Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
相关概念视频
Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
